Neural therapy can have a beneficial effect on:
- Acute and chronic pain syndrome and inflammation of the entire musculoskeletal system
- Residual/discomfort after injuries
- headaches: migraine, trigeminal neuralgia, facial pain, tension headache, chronic sinusitis, chronic tonsillitis, cervical spine syndrome, circulatory disorder of the head
- functional gastrointestinal disease: irritable bowel syndrome, constipation, gastritis
- allergy (co)treatment
- Gynecological: dys- or amenorrhea, cramping in the abdomen, menopausal symptoms, increased discharge
- Urological: irritable bladder, prostatitis (non-bacterial), prostate enlargement (early stages)
- Internal diseases: Diabetes mellitus, hypertension, thyroid dysfunction, bronchial asthma.
Neural therapy according to Huneke is an extraordinarily complex and holistic regulatory procedure. By injecting local anesthetics (local anesthetics), local and higher-level regulatory circuits are addressed. Pain and/or functional disorders are treated via the autonomic nervous system. As a local anesthetic, we only use procaine, which has been around since 1905 and has many positive effects in addition to its anesthetic function.
Weekly sessions are required at the beginning, and later at longer intervals.
Neural therapy makes use of the experience that disturbances of certain areas of the body (e.g. teeth, sinuses, scars) can have unfavorable effects also on distant areas (so-called interference fields).
Please ask your attending physician about the costs.Neural therapy is not a benefit of the statutory health insurance, not of all health insurances or professional accident insurances. In individual cases, the costs may be covered by the health insurances/insurances. However, these costs are often tax deductible.
For self-payers and privately insured persons, we bill according to the scale of fees for physicians (GOÄ).
Studies on proliferation therapy
Milne J. Ongley, Robert G. Klein, Thomas A. Dorman, Björn C. Eek, Lawrence J. Hubert
A new approach to the treatment of chronic low back pain
Lancet July 18, 1987, pp. 143-146
Scarpone M1, Rabago DP, Zgierska A, Arbogast G, Snell E.
The efficacy of prolotherapy for lateral epicondylosis: a pilot study.
Clin J Sport Med. 2008 May;18(3):248-54